NanoMedTrix has been pursuing patent recognition since its inception. The USPTO has issued patents to NMTx other disclosures have received allowances and continuances are under final review. Updated 8/17/24 Patent Number(s) in the USA 11,969,483 B2 18, 456,300
Eastern Iowa corridor spinoff continues to validate the clinical significance of the novel theranostic.
The funding supplements the NIH Phase II award, in particular commercialization efforts related to establishing a clinical trial network.
University of Iowa College of Engineering release The SBIR grant is designed to bring the technology beyond the theoretical phase and closer to clinical trials for the treatment of bladder cancer.
